Patients volunteer for trials for mostly altruistic reasons - they want to improve outcomes for others. That said, the informed consent process also allows them to gauge whether the procedure being offered is likely to be better (or the same) as the status quo.
Prof Bart Meuris (https://infomeddnews.com/valve-durability-in-tavr-is-a-critical-factor-for-the-future/) is the administering surgeon and has been working with Admedus on this for more than 5 years. He will have full and frank discussions with these patients as to whether the Admedus valve is right for them. He wouldn't be offering it if he didn't believe in it.
AHZ Price at posting:
$3.50 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)